BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 11072239)

  • 1. FGF12: biology and function.
    Biadun M; Karelus R; Krowarsch D; Opalinski L; Zakrzewska M
    Differentiation; 2023 Nov; ():100740. PubMed ID: 38042708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling the Significance of FGF8 Overexpression in Orchestrating the Progression of Ovarian Cancer.
    Chandra KB; Kumar V; Ranjan S; Saini A; Tomar AK; Sharma JB; Mathur SR; Yadav S
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine regulation of granulosa cell development in the antral follicles in mammals.
    Sugiura K; Maruyama N; Akimoto Y; Matsushita K; Endo T
    Reprod Med Biol; 2023; 22(1):e12538. PubMed ID: 37638351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rlip Depletion Alters Oncogene Transcription at Multiple Distinct Regulatory Levels.
    Hindle A; Bose C; Lee J; Palade PT; Peterson CJ; Reddy PH; Awasthi S; Singh SP
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of teneurins is associated with tumor differentiation and patient survival in ovarian cancer.
    Graumann R; Di Capua GA; Oyarzún JE; Vásquez MA; Liao C; Brañes JA; Roa I; Casanello P; Corvalán AH; Owen GI; Delgado I; Zangemeister-Wittke U; Ziegler A
    PLoS One; 2017; 12(5):e0177244. PubMed ID: 28472127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the tumor stroma in ovarian cancer.
    Davidson B; Trope CG; Reich R
    Front Oncol; 2014; 4():104. PubMed ID: 24860785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of fibroblast growth factor receptor 2 isoform IIIc: relevance to endometrioid adenocarcinoma carcinogenesis and histological differentiation.
    Peng WX; Kudo M; Fujii T; Teduka K; Naito Z
    Int J Clin Exp Pathol; 2014; 7(3):1069-76. PubMed ID: 24696723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigational agents in development for the treatment of ovarian cancer.
    Westin SN; Herzog TJ; Coleman RL
    Invest New Drugs; 2013 Feb; 31(1):213-29. PubMed ID: 22661305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation.
    Ishiwata T; Matsuda Y; Yamamoto T; Uchida E; Korc M; Naito Z
    Am J Pathol; 2012 May; 180(5):1928-41. PubMed ID: 22440254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling.
    Zecchini S; Bombardelli L; Decio A; Bianchi M; Mazzarol G; Sanguineti F; Aletti G; Maddaluno L; Berezin V; Bock E; Casadio C; Viale G; Colombo N; Giavazzi R; Cavallaro U
    EMBO Mol Med; 2011 Aug; 3(8):480-94. PubMed ID: 21739604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice.
    Elo TD; Valve EM; Seppänen JA; Vuorikoski HJ; Mäkelä SI; Poutanen M; Kujala PM; Härkönen PL
    Neoplasia; 2010 Nov; 12(11):915-27. PubMed ID: 21076617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse.
    Fon Tacer K; Bookout AL; Ding X; Kurosu H; John GB; Wang L; Goetz R; Mohammadi M; Kuro-o M; Mangelsdorf DJ; Kliewer SA
    Mol Endocrinol; 2010 Oct; 24(10):2050-64. PubMed ID: 20667984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glial-derived neurotrophic factor promotes ovarian primordial follicle development and cell-cell interactions during folliculogenesis.
    Dole G; Nilsson EE; Skinner MK
    Reproduction; 2008 May; 135(5):671-82. PubMed ID: 18304989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells.
    Sturla LM; Merrick AE; Burchill SA
    Br J Cancer; 2003 Oct; 89(7):1276-84. PubMed ID: 14520460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of fibroblast growth factor (FGF)-8 isoforms and FGF receptors in human ovarian tumors.
    Valve E; Martikainen P; Seppänen J; Oksjoki S; Hinkka S; Anttila L; Grenman S; Klemi P; Härkönen P
    Int J Cancer; 2000 Dec; 88(5):718-25. PubMed ID: 11072239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of FGF-8 isoforms and FGF receptors in human premalignant prostatic intraepithelial neoplasia lesions and prostate cancer.
    Valve EM; Nevalainen MT; Nurmi MJ; Laato MK; Martikainen PM; Härkönen PL
    Lab Invest; 2001 Jun; 81(6):815-26. PubMed ID: 11406643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
    Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
    Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
    Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoforms of receptors of fibroblast growth factors.
    Gong SG
    J Cell Physiol; 2014 Dec; 229(12):1887-95. PubMed ID: 24733629
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.